As of now, Burkina Faso reports a pregnant women living with hiv antiretroviral therapy coverage for pmtct of 84%, signifying an increase of 4% (5.0%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Burkina Faso
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Burkina Faso
PMTCT antiretroviral therapy coverage
More indicators for Burkina Faso
Burkina Faso PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 84% | +4% |
| 2021 | 80% | +8% |
| 2020 | 72% | +8% |
| 2019 | 64% | +6% |
| 2018 | 58% | +6% |
| 2017 | 52% | +6% |
| 2016 | 46% | +6% |
| 2015 | 40% | -15% |
| 2014 | 55% | +13% |
| 2013 | 42% | +3% |
| 2012 | 39% | +2% |
| 2011 | 37% | +5% |
| 2010 | 32% | +5% |
| 2009 | 27% | +11% |
| 2008 | 16% | 0% |
| 2007 | 16% | -1% |
| 2006 | 17% | +9% |
| 2005 | 8% | +5% |
| 2004 | 3% | +2% |
| 2003 | 1% | +1% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |